scispace - formally typeset
Search or ask a question
Journal ArticleDOI

A systematic review and meta-analysis of mindfulness based interventions and yoga in inflammatory bowel disease.

TL;DR: Mindfulness interventions are effective in reducing stress and depression and improving quality of life and anxiety, but do not lead to significant improvements in the physical symptoms of IBD.
About: This article is published in Journal of Psychosomatic Research.The article was published on 2019-01-01 and is currently open access. It has received 41 citations till now. The article focuses on the topics: Mindfulness & Systematic review.

Summary (5 min read)

Background

  • Mindfulness interventions are increasingly used as a part of integrated treatment in inflammatory bowel disease (IBD) but there are limited data and a lack of consensus regarding effectiveness.
  • The authors conducted a systematic review and meta-analysis of relevant randomised controlled trials (RCTs).
  • Rates of depression and anxiety in periods of remission are two to three times higher than in age matched individuals in the general population [4, 5].
  • To their knowledge, there has been only one systematic review to date examining the efficacy and use of mindfulness interventions in IBD [17], published in 2015.
  • This systematic review therefore addresses the evidence gap by exploring a wide range of mindfulness interventions and including papers published in languages other than English and German and conducted in individuals of any age.

Protocol and registration

  • This systematic review was registered with PROSPERO , an international database of prospectively registered systematic reviews (CRD42017080632) [20].
  • The authors followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement guidelines in designing this systematic review [21].
  • Ethical approval was not required as all included primary data had been previously published with ethical approval.

Design of included studies

  • Single-, double- or triple-blind RCTs were considered for inclusion.
  • Studies published as abstracts were only included if the authors were contactable and further information provided to allow evaluation of study quality and main outcomes.
  • Studies with a non RCT design and studies using non-validated outcome measures were excluded.
  • Participants AC C EP TE D M AN U SC R IP T Patients of any age, including paediatric populations, with a diagnosis of IBD were included.
  • The authors specified that the IBD diagnosis was based on established criteria, such as the Montreal classification system, including confirmation with ileocolonoscopy and biopsies of the affected tissues [20].

Interventions

  • The authors adopted a broad definition of mindfulness interventions to include any therapy or program based on mindfulness principles and involving mindfulness practices.
  • Interventions of interest included mindfulness-based programs, mindfulness-informed programs, adapted and shortened mindfulness interventions and yoga.
  • Mindfulness-based programs included MBSR and MBCT which are evidencebased, 8-week-long manualised group programs taught in weekly 2-2,5 hours sessions encompassing multiple mindfulness components, homework exercises and usually a day of silent practice [14, 23-25].
  • BBMW is an adapted program combining mindful movement, breathing practices, and meditation, delivered as a two-day workshop followed by six weekly sessions and monthly booster sessions [29].
  • For the purposes of this review, the authors divided the interventions into yoga studies and mindfulness programs involving MBSR, MBCT, adapted mindfulness programs and mindfulness informed interventions.

Comparators and context

  • Controls in the review included wait list, standard medical treatment or treatment as usual (TAU), and other evidence-based psychological interventions.
  • Studies in any clinical setting were included.

Outcomes

  • Studies examining IBD related psychological outcomes, quality of life and physical outcomes, assessed by validated screening tools were included.
  • Psychological outcomes of interest included the following: rates of depression, anxiety and stress as assessed by validated screening tools such as Depression, Anxiety and Stress Scale (DASS), Beck Depression Inventory (BDI) and Hospital Anxiety and Depression Scale (HADS) and coping as measured by the Brief Cope Questionnaire (COPE).
  • The authors extracted definitions of outcomes as reported in individual studies and recorded them in the data sheets in Covidence software [30] .

Sources of information

  • The following databases were searched: MEDLINE, EMBASE, PsycINFO and CINAHL.
  • These electronic databases searches were supplemented by searches of trial protocols and systematic reviews in the Cochrane Central Register of Controlled Trials , Australian and New Zealand Clinical Trials Register , WHO International Clinical Trials Registry Platform and the PROSPERO register of systematic reviews.
  • The authors also scanned the reference and citation lists of included studies to improve literature coverage.
  • The authors contacted the study authors for clarification and additional information when this was needed.
  • The searches were re-run prior to review completion to ensure currency.

Search strategies

  • The specific search strategies were created by a health clinical librarian with expertise in systematic review searching (KR).
  • Literature search strategies were developed using controlled vocabulary and text words related to mindfulness and IBD.

Study records

  • Data were managed by using EndNote and Covidence online software for conducting systematic reviews [30].
  • Literature search results were uploaded to EndNote and Covidence.
  • Data were extracted by one reviewer (TE) and checked for errors by a second (KR).
  • The authors used RevMan software to create a PRISMA flow diagram following the completion of the screening and data extraction.
  • Figure 1 shows the PRISMA diagram depicting the flow of studies through the systematic review.

Data selection and extraction

  • Two reviewers worked independently through all stages of the review, including screening papers for eligibility, examining full-text versions of studies for eligibility and inclusion in meta-analysis (TE, KR).
  • Any disagreements were resolved through discussion with the third author (SK) and reasons for decisions documented.

Risk of bias (quality) assessment

  • The methodological quality of the included trials was assessed independently by two reviewers using the Cochrane Collaboration's Assessment of Risk of Bias Tool [32].
  • The authors assessed risk of bias in the included studies against the six criteria from the Cochrane Risk of Bias Tool, including random sequence generation, allocation concealment, blinding of the participants and the outcome assessors, incomplete data reporting, selective data reporting and other bias .
  • The authors used risk of bias tables embeded in Covidence and adapted them by creating additional criteria involving interventions’ fidelity, validity of the outcome measures, inclusion and exclusion criteria and similarity of participants’ baseline characteristics.
  • The authors evaluated each of the criteria in the risk of bias tool as low, high or unclear risk of bias and provided decisions justification.
  • The authors did not assess publication bias due to having insufficient number of studies included in the review.

Data synthesis

  • The authors used statistical software RevMan 5.2, according to the guidelines referenced in the current version of the Cochrane Handbook for Systematic Reviews of Interventions [32].
  • Because different instruments were used across studies, standardised mean differences were specified as the effect of interest.
  • Results were presented by the two subgroups of AC C EP TE D M AN U SC R IP T mindfulness-based programs (MBPs) and yoga.
  • Where possible, the authors conducted sensitivity analyses for study quality or type of control.
  • If any meta-analysis included 10 or more studies, the authors planned to test for publication bias using funnel plot asymmetry, but only eight studies were included.

Results

  • The authors identified 202 records and removed 37 duplicates .
  • The authors excluded a further 154 after screening titles and abstracts of the remaining 165 records.
  • The authors examined the remaining 11 articles for eligibility and excluded 3 of them, two because of being conference abstracts which were superseded by the full text articles and one because of not having the RCT design.
  • The remaining 8 studies [34-41] were included in qualitative and quantitative analysis.
  • Seven were full text articles and one was a conference abstract (Rowan 2017) which was assessed from the abstract content and by enlarging the reported graphs and then measuring and analysing the illustrated outcomes.

Study quality (Risk of Bias)

  • Allocation concealment was not adequately described in 5 out of the 8 included studies.
  • Due to the nature of the intervention, it was difficult to blind the participants as they were aware of their group allocation in studies with waitlist and TAU controls.
  • There was also a significant proportion of studies with incomplete reporting with 6 studies having inadequate or incomplete data reporting.
  • All the others used complete case or per protocol population analysis.
  • Three out of eight studies described fidelity measures, both of the yoga studies and the MBCT study.

Participants’ characteristics

  • All the participants were adults as no paediatric studies met the inclusion criteria.
  • In all the studies, IBD was diagnosed with a combination of clinical, laboratory and endoscopic findings as per the widely accepted criteria.
  • All studies enrolled individuals with quiescent IBD or IBD in remission and excluded individuals with significant mental health diagnoses.

Interventions Characteristics

  • Two studies involved Mindfulness Based Programs (MBPs) , one MBSR [38] and one MBCT[42] , two of the studies used ACT, one MCT, one BBMW and two studies delivered yoga.
  • Duration of therapy was between 6 and 12 weeks (Table 1).
  • The shortest mindfulness intervention was BBMW with only 6 weeks duration, however it had an intensive two-day start and was followed by monthly booster sessions up till 26 weeks.
  • The longest intervention was MCT of 16 weeks duration but with only 6 sessions delivering a similar “dose” of mindfulness practices to the other interventions.

Comparators’ characteristics

  • All included studies had a parallel group allocation design.
  • Control groups were wait list patients in five out of eight studies, one had a written self-care control group and two studies had active controls.
  • In both studies with active controls, participants in the control group were receiving treatment that mimicked the amount of time and attention received by the treatment group but thought not to have significant therapeutic effect, referred to as attention placebo control [43].
  • Outcomes characteristics and outcomes collection time points Seven of the eight included studies measured both psychological and biological outcomes and all studies measured psychological outcomes.
  • For the purpose of this review, the authors classified post treatment outcomes collection point as a short-term follow-up which occurred 6-16 weeks post baseline, depending on the length of the intervention.

Psychological Outcomes Changes in Response to Mindfulness Interventions

  • Eight studies were included in the meta-analysis, providing data for 251 participants who received mindfulness interventions and 249 waitlist, TAU or active controls (Table 1).
  • Short-term psychological symptoms Outcome or Subgroup Studies Participants Standardised mean difference [95% CI], also known as Table 3.
  • There was no significant difference in depression scores between people who received mindfulness and those in the control group in the short-term.
  • These results were mirrored in the subgroup analyses of MBPs and yoga in the long-term but not the short-term .

Quality of Life Changes in Response to Mindfulness Interventions

  • Three studies reported on the QoL outcome at each time-point but only two were common to both times.
  • When the mindfulness and yoga interventions were combined in a single analysis, there was evidence for a statistically greater improvement in the long-term effect estimates , but not the short-term (Table 3).
  • None of the results in the subgroup analyses reached statistical significance (Tables 3 and 4).

Physical Outcomes Changes in Response to Mindfulness Interventions

  • There was limited information on physical disease outcomes, including systemic inflammatory markers (ESR/CRP), local inflammatory markers (FCP) and clinical disease activity.
  • Only one MBP and one yoga study reported short term physical outcomes, both reporting non-significant results.
  • Long-term physical outcomes were reported by two MBPs and one yoga study.

Discussion

  • This review is the first systematic review to explore the efficacy of a broad range of mindfulness interventions in IBD while including all population ages and settings and posing no language or time and type of publication restrictions.
  • Expanding the language only brought one additional study, published in Farsi, because the study conducted in Germany (Cramer 2017) and the study conducted in India (Sharma 2015) were both published in English.
  • One of the yoga studies, Cramer et al, outperformed all other mindfulness interventions in depression, anxiety and stress scores changes both short and longterm and in stress scores long-term.
  • Furthermore, the quality of individual studies has been affected by poor blinding of the outcome assessors, incomplete data reporting and a relative lack of fidelity measures.
  • The review suggests the need for mindfulness interventions that are tailored for IBD which could improve participants’ engagement and potentially increase their effect via a doseresponse relationship.

Contributions

  • Systematic review was conceived and designed by TE, SK and KR and critically revised by SK, MK, JB and KH.
  • Drafting of the paper was completed by TE.

Declarations of interests

  • None AC C EP TE D M AN U SC R IP T References 1. Kumar, V., C. Wijmenga, and R.J. Xavier, Genetics of immune-mediated disorders: from genomewide association to molecular mechanism.
  • Hofmann, S.G., et al., The Effect of Mindfulness-Based Therapy on Anxiety and Depression: A Meta-Analytic Review.
  • Journal of Consulting and Clinical Psychology, 2010.
  • Berrill, J.W., et al., Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels.

Did you find this useful? Give us your feedback

Citations
More filters
Journal ArticleDOI
TL;DR: Current understanding of the comorbidity of gastrointestinal diseases and psychological disorders is reviewed and the current evidence supporting the key role of the brain-gut-microbiome axis (BGMA) is reviewed.
Abstract: The high comorbidity of psychological disorders in both functional and organic gastrointestinal diseases suggests the intimate and complex link between the brain and the gut. Termed the brain-gut axis, this bidirectional communication between the central nervous system and enteric nervous system relies on immune, endocrine, neural, and metabolic pathways. There is increasing evidence that the gut microbiome is a key part of this system, and dysregulation of the brain-gut-microbiome axis (BGMA) has been implicated in disorders of brain-gut interaction, including irritable bowel syndrome, and in neuropsychiatric disorders, including depression, Alzheimer's disease, and autism spectrum disorder. Further, alterations in the gut microbiome have been implicated in the pathogenesis of organic gastrointestinal diseases, including inflammatory bowel disease. The BGMA is an attractive therapeutic target, as using prebiotics, probiotics, or postbiotics to modify the gut microbiome or mimic gut microbial signals could provide novel treatment options to address these debilitating diseases. However, despite significant advancements in our understanding of the BGMA, clinical data is lacking. In this article, we will review current understanding of the comorbidity of gastrointestinal diseases and psychological disorders. We will also review the current evidence supporting the key role of the BGMA in this pathology. Finally, we will discuss the clinical implications of the BGMA in the evaluation and management of psychological and gastrointestinal disorders.

28 citations

Journal ArticleDOI
TL;DR: The findings confirm the importance of perceived stress in reducing disease activity and increasing health-related quality of life in patients with ulcerative colitis and impairedquality of life and practitioners should keep psychosocial risk in mind as a risk factor for disease exacerbation.

17 citations

Journal ArticleDOI
TL;DR: In this article, the authors conducted a meta-review, using a literature search from inception to June 2020 in several electronic databases using a combination of keywords including MBSR, MBCT, cancer, and meta-analysis OR "systematic review".
Abstract: OBJECTIVE A large number of studies have been conducted exploring the effects of mindfulness programs on health outcomes, such as psychological and biological outcomes. However, there is substantial heterogeneity among studies and, consequently, in the systematic reviews/meta-analyses. Since clinical practice is massively informed by evidence on review studies, our main objective was to summarize the reported evidence regarding the effects of structured mindfulness-based programs on psychological, biological, and quality-of-life outcomes in cancer patients. METHODS We conducted a meta-review, using a literature search from inception to June 2020 in several electronic databases using a combination of keywords including MBSR, MBCT, cancer, and meta-analysis OR "systematic review" (PROSPERO registration CRD42020186511). RESULTS Ten studies met the eligibility criteria and were included. The main findings were beneficial small to medium effect sizes of Mindfulness-Based Stress Reduction (MBSR)/Mindfulness-Based Cognitive Therapy (MBCT)/Mindfulness-Based Cancer Recovery (MBCR) on psychological health, such as anxiety, depression, stress, and quality of life. A beneficial effect was found for biological outcomes, albeit based on a reduced number of studies. Studies were moderate homogenous regarding the intervention, population, and outcomes explored. Results on long-term follow-up seem to indicate that the effects tend not to be maintained, namely in shorter follow-ups (6 months). CONCLUSIONS This meta-review brings a broad perspective on the actual evidence regarding MBSR/MBCT/MBCR. We expect to contribute to future project design, focused on developing high-quality studies and exploring the moderating effects that might contribute to biased results, as well as exploring who might benefit more from MBSR/MBCT/MBCT interventions.

11 citations

Journal ArticleDOI
TL;DR: In this article, the authors evaluated feasibility and efficacy of an adapted mindfulness-based cognitive therapy (MBCT) program for adolescents and young adults (AYAs) with Inflammatory Bowel Disease (IBD) and comorbid depression.

10 citations

Journal ArticleDOI
TL;DR: The CSM can be utilised in IBD cohorts to evaluate key psychosocial processes that influence PROs and the efficacy of targeting CSM processes to promote psychological well-being and QoL in I BD cohorts is evaluated.

10 citations

References
More filters
Journal ArticleDOI
11 Apr 2015-Trials
TL;DR: The tension between methodological and ethical requirements of an APC group in psychosocial interventions is discussed based on the experiences with a randomized controlled efficacy study of a parent training program.
Abstract: Attention placebo control (APC) is considered a highly valid control condition when conducting trials of social interventions. Unfortunately, an appropriate APC condition is rarely used. This letter discusses the tension between methodological and ethical requirements of an APC group in psychosocial interventions based on our experiences with a randomized controlled efficacy study of a parent training program. To prevent negative side effects and high drop-out rates, feasible and accepted attention control conditions are discussed. The paradigms of placebo research must be adapted to the special challenges of psychosocial intervention research.

68 citations

Journal ArticleDOI
TL;DR: Mind–body interventions, such as BBMW, which emphasize Voluntarily Regulated Breathing Practices, may have significant long-lasting benefits for IBD symptoms, anxiety, depression, quality of life, and inflammation.
Abstract: Background This study evaluated the effects of the Breath-Body-Mind Workshop (BBMW) (breathing, movement, and meditation) on psychological and physical symptoms and inflammatory biomarkers in inflammatory bowel disease (IBD). Methods Twenty-nine IBD patients from the Jill Roberts IBD Center were randomized to BBMW or an educational seminar. Beck Anxiety Inventory, Beck Depression Inventory, Brief Symptom Inventory 18, IBD Questionnaire, Perceived Disability Scale, Perceived Stress Questionnaire, Digestive Disease Acceptance Questionnaire, Brief Illness Perception Questionnaire, fecal calprotectin, C-reactive protein, and physiological measures were obtained at baseline and weeks 6 and 26. Results The BBMW group significantly improved between baseline and week 6 on Brief Symptom Inventory 18 (P = 0.02), Beck Anxiety Inventory (P = 0.02), and IBD Questionnaire (P = 0.01) and between baseline and week 26 on Brief Symptom Inventory 18 (P = 0.04), Beck Anxiety Inventory (P = 0.03), Beck Depression Inventory (P = 0.01), IBD Questionnaire (P = 0.01), Perceived Disability Scale (P = 0.001), and Perceived Stress Questionnaire (P = 0.01) by paired t tests. No significant changes occurred in the educational seminar group at week 6 or 26. By week 26, median C-reactive protein values decreased significantly in the BBMW group (P = 0.01 by Wilcoxon signed-rank test) versus no significant change in the educational seminar group. Conclusions In patients with IBD, participation in the BBMW was associated with significant improvements in psychological and physical symptoms, quality of life, and C-reactive protein. Mind-body interventions, such as BBMW, which emphasize Voluntarily Regulated Breathing Practices, may have significant long-lasting benefits for IBD symptoms, anxiety, depression, quality of life, and inflammation. BBMW, a promising adjunctive treatment for IBD, warrants further study.

64 citations

Journal ArticleDOI
TL;DR: A simplified yoga-based regimen is a safe and effective complementary clinical treatment modality for patients with inflammatory bowel disease during the clinical remission phase.
Abstract: Background: Inflammatory bowel disease (IBD) is a chronic illness characterized by gross inflammation in the gastrointestinal tract that can result in symptoms such as abdominal pain, cramping, diarrhea, and bloody stools. IBD is believed to be influenced by psychological factors such as stress and anxiety. Therefore, a yoga intervention that reduces stress and anxiety may be an effective complementary treatment for these disorders. Material and Methods: A total of 100 IBD patients [ulcerative colitis (UC) n = 60 and Crohn's disease (CD) n = 40] during the clinical remission phase of disease were included in the study. These patients were allocated randomly to either the yoga group that underwent an 8-week yoga intervention (physical postures, pranayama, and meditation) 1- hour/day in addition to standard medical therapy (UC, n = 30; CD, n = 20) or the control group (UC, n = 30; CD n = 20), which continued with standard medical therapy alone. The main outcome measures were cardiovascular autonomic functio...

55 citations

Journal ArticleDOI
TL;DR: It is proposed that the interdisciplinary studies (genetics-genomics-immunology-infection-bioinformatics) are the future post-GWAS approaches to advance the understanding of the pathogenesis of immune-mediated diseases.

40 citations

Journal ArticleDOI
TL;DR: Initial follow-up data showed that patients were benefiting from this individualised form of therapy and data indicated that Multi Convergent Therapy provides improvements in objective measures of psychomotor performance and cognition.
Abstract: Objectives: Multi Convergent Therapy combines approaches such as Cognitive Behaviour Therapy and Graded Exercise Therapy in an holistic treatment of Chronic Fatigue Syndrome. Initial follow-up data showed that patients were benefiting from this individualised form of therapy. The objective of the present study was to evaluate this Multi Convergent approach, developed at a specialised Chronic Fatigue Syndrome Outpatient clinic in Cardiff, and compare it to Relaxation Therapy and control groups using multiple outcome measures. Design: Thirty-five participants fitting the Centre for Disease Control criteria for Chronic Fatigue Syndrome were recruited from two outpatient clinics and members of our existing patient panel. Patients were assigned to Multi Convergent Therapy (N=12), Relaxation Therapy (N=14) or recruited as controls (N=9). Methods: Each patient completed a battery of mood and performance tasks along with comprehensive set of questionnaires at baseline, post-treatment and at six-month follow-up. These measures had been validated in previous studies on untreated patients and matched healthy controls. Results: Patients attending the Multi Convergent Therapy clinic showed statistically significant improvements in many of our measures. Most importantly we have produced data indicating that Multi Convergent Therapy provides improvements in objective measures of psychomotor performance and cognition. Discussion: The outcomes of this small study are encouraging. Multi Convergent Therapy has not only produced results indicating significant improvements in standardised questionnaire based measures but also in objective cognitive performance tasks. The next step would be to assess Multi Convergent Therapy at the primary medical care level, with a greater number of patients to further evaluate its efficacy as a treatment for Chronic Fatigue Syndrome.

33 citations